老虎证券

BUZZ-Catalyst rises on upbeat 2025 revenue forecast, quarterly results beat

Reuters
2025/02/28
BUZZ-Catalyst rises on upbeat 2025 revenue forecast, quarterly results beat

** Shares of drugmaker Catalyst Pharmaceuticals CPRX.O rise 7.9% to $22.21

** Company late on Wednesday forecast 2025 revenue in the range of $545 million to $565 millionn, analysts on average expect revenue to be $556.9 million, as per data compiled by LSEG

** CPRX posted fourth-quarter revenue of $141.8 million, beating analysts' estimate of $134.2 million

** Reported adj quarterly profit of 70 cents/share vs analysts' estimate of 34 cents/share

** Stock has risen 41.1% in the past 12 months

(Reporting by Padmanabhan Ananthan)

((Padmanabhan.Ananthan@thomsonreuters.com))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10